Determination of suramin in plasma by high-performance liquid chromatographyEDWARDS, G; RODICK, C. L; WARD, S. A et al.Journal of chromatography. 1985, Vol 343, Num 1, pp 224-228, issn 0021-9673Article

Rapid high-performance liquid chromatographic determination of suramin in plasma of patients with acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC)TEIRLYNCH, O; BOGAERT, M. G; DEMEDTS, P et al.Journal of pharmaceutical and biomedical analysis. 1989, Vol 7, Num 1, pp 123-126, issn 0731-7085Article

Sequence analysis of suramin and diarylene ureas by negative ion fast atom bombardment and MS/MSHOLZMANN, G; OSTWALD, U; NICKEL, P et al.Biomedical mass spectrometry. 1985, Vol 12, Num 11, pp 659-663, issn 0306-042XArticle

Suramin : an anticancer drug with unique biological effectsLARSEN, A. K.Cancer chemotherapy and pharmacology. 1993, Vol 32, Num 2, pp 96-98, issn 0344-5704Conference Paper

Suramin, a novel antitumor compoundLA ROCCA, R. V; STEIN, C. A; DANESI, R et al.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 893-898, issn 0960-0760, 6 p.Conference Paper

Chemical stability of suramin in commonly used infusion fluidsBEIJNEN, J. H; VAN GIJN, R; HORENBLAS, S et al.DICP (Cincinnati, Ohio). 1990, Vol 24, Num 11, pp 1056-1058, issn 1042-9611, 3 p.Article

Cutanous eruptions from suramin : a clinical and histopathologic study of 60 patientsLOWITT, M. H; EISENBERG, M; SINA, B et al.Archives of dermatology (1960). 1995, Vol 131, Num 10, pp 1147-1153, issn 0003-987XArticle

Bioanalysis of suraminin human plasma by ion-pair high-performance liquid chromatographyTJADEN, U. R; REEUWIJK, H. J. E. M; VAN DER GREEF, J et al.Journal of chromatography. Biomedical applications. 1990, Vol 525, Num 1, pp 141-149, issn 0378-4347Article

Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiationREGMI, Ajit; FUSON, Tina; XUHAO YANG et al.Bone (New York, NY). 2005, Vol 36, Num 2, pp 284-291, issn 8756-3282, 8 p.Article

Stability of suramin in aqueous solution ; Possible implications for the search for suramin metabolites in patientsKASSACK, M; NICKEL, P.Archiv der Pharmazie (Weinheim). 1996, Vol 329, Num 5, pp 225-228, issn 0365-6233Article

Suramine : une nouvelle destinée pour un vieux médicament = Suramin: a new future for an old drugSOULIE, P; CVITKOVI, E; ARMAND, J. P et al.La Revue du praticien (Paris). 1994, Vol 44, Num 10, pp 1358-1361, issn 0035-2640Article

Peroxidative potential of suramin and effect on organic ion transport in rat kidney cortexHANNEMANN, J; BAUMANN, K.Toxicology letters. 1990, Vol 53, Num 1-2, pp 187-188, issn 0378-4274, 2 p.Conference Paper

Uptake of suramin by human microvascular endothelial cellsGAGLIARDI, A. R. T; TAYLOR, M. F; COLLINS, D. C et al.Cancer letters. 1998, Vol 125, Num 1-2, pp 97-102, issn 0304-3835Article

Liposomal entrapment of suraminHUNG-CHIH CHANG; FLANAGAN, D. R.Journal of pharmaceutical sciences. 1994, Vol 83, Num 7, pp 1043-1046, issn 0022-3549Article

Modulation by suramin of NK and monocytic cell-mediated cytotoxicity in human and murine cellsHONG-XIANG ZHANG; SOZZANI, S; D'ALESSANDRO, F et al.International journal of immunopharmacology. 1988, Vol 10, Num 6, pp 695-707, issn 0192-0561Article

Inhibition of angiogenesis with combination treatments of angiostatic steroids and suraminWILKS, J. W; SCOTT, P. S; VRBA, L. K et al.International journal of radiation biology (Print). 1991, Vol 60, Num 1-2, pp 73-77, issn 0955-3002Conference Paper

A pilot study of suramin in the treatment of progressive refractory follicular lymphomasLA ROCCA, R. V; COOPER, M. R; STEIN, C. A et al.Annals of oncology. 1992, Vol 3, Num 7, pp 571-573, issn 0923-7534Article

A rapid isocratic HPLC assay of suramin (NSC 34936) in human plasmaSUPKO, J. G; MALSPEIS, L.Journal of liquid chromatography. 1990, Vol 13, Num 4, pp 727-741, issn 0148-3919, 15 p.Article

Trypanosoma brucei evansi : dyskinetoplasia and loss of infectivity after long-term in vitro cultivationZWEYGARTH, E; KAMINSKY, R; WEBSTER, P et al.Acta tropica. 1990, Vol 48, Num 2, pp 95-99, issn 0001-706X, 5 p.Article

Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infectionCOLLINS, J. M; KLECKER, R. W; YARCHOAN, R et al.Journal of clinical pharmacology. 1986, Vol 26, Num 1, pp 22-26, issn 0091-2700Article

Analysis of suramin plasma levels by ion-pair high-performance liquid chromatography under isocratic conditionsRUPRECHT, R. M; LORSCH, J; TRITES, D. H et al.Journal of chromatography. 1986, Vol 378, Num 2, pp 498-502, issn 0021-9673Article

Suramin antiviral therapy in the acquired immunodeficiency syndrome: clinical, immunologic, and virologic resultsLEVINE, A. M; GILL, P. S; COHEN, J et al.Annals of internal medicine. 1986, Vol 105, Num 1, pp 32-37, issn 0003-4819Article

Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesisBAHRAMSOLTANI, Mahtab; PLENDL, Johanna.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2007, Vol 115, Num 1, pp 30-46, issn 0903-4641, 17 p.Article

Suramin blocks the binding of interleukin-1 to its receptor and neutralizes IL-1 biological activitiesSTRASSMANN, G; D'ALESSANDRO, F; MIRANDA FONG et al.International journal of immunopharmacology. 1994, Vol 16, Num 11, pp 931-939, issn 0192-0561Article

Effects of the P₂-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphateHOURANI, S. M. O; HALL, D. A; NIEMAN, C. J et al.British journal of pharmacology. 1992, Vol 105, Num 2, pp 453-457, issn 0007-1188Article